These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30311450)

  • 1. Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population-based study.
    Tian FX; Cai YQ; Zhuang LP; Chen MF; Xiu ZB; Zhang Y; Liu H; Liu ZH; Liu GP; Zeng C; Lin FL; Liu J; Huang ST; Zhang LZ; Lin HY
    Cancer Med; 2018 Nov; 7(11):5359-5369. PubMed ID: 30311450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.
    Yang Z; Wang W; Lu J; Pan G; Pan Z; Chen Q; Liu W; Zhao Y
    Cell Physiol Biochem; 2018; 45(1):389-396. PubMed ID: 29402806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.
    Hu P; Bai J; Liu M; Xue J; Chen T; Li R; Kuai X; Zhao H; Li X; Tian Y; Sun W; Xiong Y; Tang Q
    Gastric Cancer; 2020 Jul; 23(4):591-599. PubMed ID: 32026156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival.
    Chen QY; Zhong Q; Wang W; Chen S; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Liu ZY; Zheng CH; Peng JS; Zhou ZW; Huang CM
    Oncologist; 2019 Jun; 24(6):e260-e274. PubMed ID: 30470692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary neuroendocrine tumors of the ovary: Management and outcomes.
    Pang L; Guo Z
    Cancer Med; 2021 Dec; 10(23):8558-8569. PubMed ID: 34773393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
    Xu B; Chu Y; Hu Q; Song Q
    Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
    Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
    Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
    Li YF; Zhang QQ; Wang WL
    Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
    Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
    JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study.
    Chen QY; Zhong Q; Zhou JF; Qiu XT; Dang XY; Cai LS; Su GQ; Xu DB; Lin GT; Guo KQ; Liu ZY; Chen QX; Li P; Li TW; Xie JW; Lin SM; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Zheng CH; Lin W; He QL; Huang CM
    Cancer Sci; 2020 Feb; 111(2):502-512. PubMed ID: 31710406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution.
    Yang M; Tan CL; Zhang Y; Ke NW; Zeng L; Li A; Zhang H; Xiong JJ; Guo ZH; Tian BL; Liu XB
    Medicine (Baltimore); 2016 Jul; 95(28):e4213. PubMed ID: 27428224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
    Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
    Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases.
    Han Y; Liu C
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2460-2472. PubMed ID: 33870589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors.
    Chi W; Warner RRP; Chan DL; Singh S; Segelov E; Strosberg J; Wisnivesky J; Kim MK
    Pancreas; 2018 Mar; 47(3):321-325. PubMed ID: 29401168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival comparison between endoscopic and surgical resection for non-ampullary duodenal neuroendocrine tumor (1-2 cm).
    Xie J; Zhang Y; He M; Liu X; Xie P; Pang Y
    Sci Rep; 2022 Sep; 12(1):15339. PubMed ID: 36097200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
    Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
    Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.